Infertility
GnRH agonist treats empty follicle syndrome by triggering hormone surges
Published in Women's Health Weekly, November 20th, 2003
According to published research from England, "to date, empty follicle syndrome (EFS) has only been reported in gonadotropin-releasing hormone (GnRH) agonist down-regulated in vitro fertilization (IVF) cycles. Some cases have been successfully treated by changing the batch, or by repeating the dose of human chorionic gonadotropin (hCG). A case of EFS was observed in both GnRH antagonist and GnRH agonist down-regulated IVF cycles when final oocyte maturation was triggered using urinary hCG (u-hCG)."
"Failure to retrieve oocytes occurred, despite administration of a further dose...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Gynecology
Self-collected vaginal swabs are reliable for bacterial vaginosis screening - Osteoporosis
Raloxifene staunches the risk for new vertebral fractures in osteopenic women - Breast Cancer
Alcohol use boosts risk of hormonally sensitive breast cancers in older women - Domestic Violence
Presentation package helps healthcare providers identify, help battered women - Neuroscience
Accelerated estrogen loss hastens Alzheimer Disease - Urinary Incontinence
New treatment could "revolutionize" management of severe incontinence - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
